Estrogen Management on TRT: Anastrozole, Exemestane, and Aromasin Guide

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Estrogen management on TRT involves monitoring E2 levels and using aromatase inhibitors (AIs) only when symptomatic with confirmed high E2. Anastrozole (0.25–0.5 mg twice weekly) and Exemestane (12.5–25 mg every other day) are the most common AIs. Over-suppressing E2 causes joint pain, low libido, and cardiovascular risk.

Why Estrogen Management Matters on TRT

When men take exogenous testosterone, a portion of it is converted to estradiol (E2) by the enzyme aromatase, found primarily in adipose tissue. While estrogen is often thought of as a "female hormone," it plays essential roles in male physiology: bone density maintenance, cardiovascular health, cognitive function, libido, and joint lubrication. The goal of estrogen management on TRT is not to eliminate estrogen but to maintain it within an optimal range — typically 20–40 pg/mL on the sensitive estradiol assay.

Symptoms of High Estrogen

Elevated estradiol on TRT can cause: water retention and bloating, gynecomastia, mood swings and emotional sensitivity, reduced libido, erectile dysfunction, and fatigue. These symptoms overlap significantly with symptoms of low testosterone, making laboratory confirmation of elevated E2 essential before initiating AI therapy.

Symptoms of Low Estrogen

Over-suppression of estrogen produces: joint pain and stiffness, low libido, cognitive impairment, cardiovascular risk, bone loss, and depression. Many men who feel poorly on TRT are actually suffering from over-suppressed estrogen from excessive AI use.

Anastrozole

Anastrozole (Arimidex) is a non-steroidal aromatase inhibitor that reversibly blocks the aromatase enzyme. Typical dosing: 0.25–0.5 mg twice weekly, adjusted based on E2 laboratory values and symptoms. Anastrozole is highly potent — small dose changes can produce large swings in E2 levels, making careful titration essential.

Exemestane

Exemestane (Aromasin) is a steroidal aromatase inhibitor that permanently inactivates the aromatase enzyme. New aromatase enzyme must be synthesized to restore aromatase activity, which takes several days. Typical dosing: 12.5–25 mg every other day. Exemestane also has mild anabolic properties due to its steroidal structure.

When to Use an AI

AIs should be used only when E2 is confirmed elevated on laboratory testing AND the patient has symptoms attributable to elevated estrogen. Many men on TRT do not need an AI at all, particularly those who inject more frequently (every 3.5 days).